Literature DB >> 23850406

Willingness to undergo surgery again validated clinically important differences in health-related quality of life after total hip replacement or total knee replacement surgery.

J Christiaan Keurentjes1, Marta Fiocco, Rob G Nelissen.   

Abstract

OBJECTIVES: To determine clinically important differences (CIDs) in health-related quality of life (HRQoL) after total hip replacement (THR) or total knee replacement (TKR) surgery, using the Short Form 36 (SF-36). STUDY DESIGN AND
SETTING: SF-36 scores were collected 2 weeks before and at 1.5-6 years after joint replacement in 586 THR and 400 TKR patients in a multicenter cohort study. We calculated distribution-based CIDs (0.8 standard deviations of the preoperative score) for each SF-36 subscale. Responders (patients with an improvement in HRQoL ≥ CID of a particular subscale) were compared with nonresponders using an external validation question: willingness to undergo surgery again.
RESULTS: CIDs for THR/TKR were physical functioning (PF), 17.9/16.7; role-physical (RP), 31.1/33.4; bodily pain (BP), 16.8/16.2; general health, 15.5/15.7; vitality, 17.3/16.7; social functioning (SF), 22.0/19.9; role-emotional, 33.7/33.6; and mental health, 14.8/14.1. CIDs of PF, RP, BP, and SF were validated by the validation question.
CONCLUSION: Valid and precise CIDs are estimated of PF, RP, BP, and SF, which are relevant in HRQoL subscales for THR and TKR patients. CIDs of all other subscales should be used cautiously.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinically important differences; Health-related quality of life; Short form 36; Total hip replacement; Total knee replacement

Mesh:

Year:  2013        PMID: 23850406     DOI: 10.1016/j.jclinepi.2013.04.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Is there any difference in survivorship of total hip arthroplasty with different bearing surfaces? A systematic review and network meta-analysis.

Authors:  Si Yin; Dangfeng Zhang; Hui Du; Heng Du; Zhanhai Yin; Yusheng Qiu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  CORR Insights(®): Standard Comorbidity Measures Do Not Predict Patient-reported Outcomes 1 Year After Total Hip Arthroplasty.

Authors:  J Christiaan Keurentjes
Journal:  Clin Orthop Relat Res       Date:  2015-03-20       Impact factor: 4.176

3.  Hip and knee replacement patients prefer pen-and-paper questionnaires: Implications for future patient-reported outcome measure studies.

Authors:  J C Keurentjes; M Fiocco; C So-Osman; R Ostenk; A W M M Koopman-Van Gemert; R G Pöll; R G H H Nelissen
Journal:  Bone Joint Res       Date:  2013-11-07       Impact factor: 5.853

4.  Age- and health-related quality of life after total hip replacement: decreasing gains in patients above 70 years of age.

Authors:  Max Gordon; Meridith Greene; Paolo Frumento; Ola Rolfson; Göran Garellick; André Stark
Journal:  Acta Orthop       Date:  2014-04-30       Impact factor: 3.717

5.  Equal tibial component fixation of a mobile-bearing and fixed-bearing medial unicompartmental knee arthroplasty: a randomized controlled RSA study with 2-year follow-up.

Authors:  Daan Koppens; Søren Rytter; Stig Munk; Jesper Dalsgaard; Ole G Sørensen; Torben B Hansen; Maiken Stilling
Journal:  Acta Orthop       Date:  2019-07-11       Impact factor: 3.717

6.  Meaningful values in the Short Form Health Survey-36 after total knee arthroplasty - an alternative to the EuroQol five-dimension index as a measure for health-related quality of life : minimal clinically important difference, minimal important change, patient-acceptable symptom state thresholds, and responsiveness.

Authors:  Nick D Clement; David Weir; David Deehan
Journal:  Bone Joint Res       Date:  2022-07       Impact factor: 4.410

7.  Patient acceptable symptom states after totalhip or knee replacement at mid-term follow-up: Thresholds of the Oxford hip and knee scores.

Authors:  J C Keurentjes; F R Van Tol; M Fiocco; C So-Osman; R Onstenk; A W M M Koopman-Van Gemert; R G Pöll; R G H H Nelissen
Journal:  Bone Joint Res       Date:  2014-01-13       Impact factor: 5.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.